Authors:
SCHRODER J
ESTEBAN M
MULLER MR
KASIMIRBAUER S
BAMBERGER U
HECKEL A
SEEBER S
SCHEULEN ME
Citation: J. Schroder et al., MODULATION OF MULTIDRUG-RESISTANCE BY BIBW22BS IN BLASTS OF DE-NOVO OR RELAPSED OR PERSISTENT ACUTE MYELOID-LEUKEMIA EX-VIVO, Journal of cancer research and clinical oncology, 122(5), 1996, pp. 307-312
Authors:
LIU Z
LHEUREUX F
POULIOT JF
HECKEL A
BAMBERGER U
GEORGES E
Citation: Z. Liu et al., BIBW22 BS, POTENT MULTIDRUG RESISTANCE-REVERSING AGENT, BINDS DIRECTLY TO P-GLYCOPROTEIN AND ACCUMULATES IN DRUG-RESISTANT CELLS, Molecular pharmacology, 50(3), 1996, pp. 482-492
Authors:
JANSEN WJM
PINEDO HM
VANDERWILT CL
FELLER N
BAMBERGER U
BOVEN E
Citation: Wjm. Jansen et al., THE INFLUENCE OF BIEW22BS, A DIPYRIDAMOLE DERIVATIVE, ON THE ANTIPROLIFERATIVE EFFECTS OF 5-FLUOROURACIL, METHOTREXATE AND GEMCITABINE IN-VITRO AND IN HUMAN TUMOR XENOGRAFTS, European journal of cancer, 31A(13-14), 1995, pp. 2313-2319
Authors:
LIST AF
CHAKOS H
GLINSMANNGIBSON B
BAMBERGER U
Citation: Af. List et al., REVERSAL OF CLASSICAL AND NON-PI-P-GLYCOPROTEIN (PGP) MEDIATED MULTIDRUG-RESISTANCE (MDR) BY BIBW22, Blood, 86(10), 1995, pp. 2052-2052
Authors:
JANSEN WJM
PINEDO HM
KUIPER CM
LINCKE C
BAMBERGER U
HECKEL A
BOVEN E
Citation: Wjm. Jansen et al., BIOCHEMICAL MODULATION OF CLASSICAL MULTIDRUG-RESISTANCE BY BIBW22BS,A POTENT DERIVATIVE OF DIPYRIDAMOLE, Annals of oncology, 5(8), 1994, pp. 733-739
Citation: Ch. Ladel et al., LOCALIZATION OF HUMAN PERIPHERAL-BLOOD LEUKOCYTES AFTER TRANSFER TO CB-17 SCID SCID MICE, Immunology letters, 38(1), 1993, pp. 63-68
Authors:
CHEN HX
BAMBERGER U
HECKEL A
GUO X
CHENG YC
Citation: Hx. Chen et al., BIBW-22, A DIPYRIDAMOLE ANALOG, ACTS AS A BIFUNCTIONAL MODULATOR ON TUMOR-CELLS BY INFLUENCING BOTH P-GLYCOPROTEIN AND NUCLEOSIDE TRANSPORT, Cancer research, 53(9), 1993, pp. 1974-1977
Authors:
DIECKMANNSCHUPPERT A
BAMBERGER U
SCHWARZ RT
Citation: A. Dieckmannschuppert et al., CHLOROQUINE RESISTANCE IN PLASMODIUM-FALCIPARUM IS NOT REVERSED BY BIBW-22, A COMPOUND REVERSING THE MULTIDRUG-RESISTANCE PHENOTYPE IN MAMMALIAN CANCER-CELLS, Biochemical pharmacology, 46(8), 1993, pp. 1421-1424